Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3041082	s-gbmif	— (—)	242	278	100.00%	Distribution not available
3041082	s-gbmif	titre (titre)	7	14	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Renal failure

105

18.19

123.77

1.1

362.00

—

titre

—

Glomerular diseases

27.51

116.37

1.4

1.2

438.57

—

titre

—

Acute renal failure

28.38

92.24

1.1

1.0

362.00

—

titre

—

Chronic kidney disease

17.18

81.16

1.1

362.00

—

titre

—

Glomerular disorders in diseases classified elsewhere

37.30

77.28

1.6

1.0

438.57

—

titre

—

ILD medications: immunosuppressive drugs

9.17

67.31

1.2

1.1

510.00

—

titre

—

ILD medications

122

7.13

61.35

1.3

1.1

470.00

—

titre

—

Implicit Sepsis

7.22

54.12

1.1

362.00

—

titre

—

Dialysis, with operation codes

20.15

52.10

1.2

1.1

610.00

—

titre

—

ILD medications: prednisolone, methylprednisolone, prednisone

107

6.58

51.38

1.3

1.1

470.00

—

titre

—

Nephropathy related operations

17.22

49.70

1.2

1.0

610.00

—

titre

—

First line medication for Crohn's disease

109

100

5.95

47.25

1.3

1.1

470.00

—

titre

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

101

132

5.49

46.19

1.2

—

303.33

—

Systemic connective tissue disorders

7.44

32.17

1.6

1.0

438.57

—

titre

—

Autoimmune diseases

119

3.69

21.96

1.2

1.1

562.00

—

titre

—

Nephrotic syndrome

34.51

21.18

1.0

—

Other necrotizing vasculopathies

40.39

19.50

2.2

1.0

438.57

—

titre

—

Unspecified kidney failure

27.94

18.70

1.1

1.0

—

Heart failure and antihypertensive medication

10.34

17.99

1.0

1.1

—

Autoimmune diseases related-to ILD

161

3.33

16.30

1.5

1.1

438.57

—

titre

—

Examination and observation for other reasons

3.70

12.51

1.1

—

610.00

—

Other systemic involvement of connective tissue (FG)

6.42

12.24

1.0

1.1

—

Other systemic involvement of connective tissue

4.90

10.24

1.0

—

Metabolic disorders

130

2.68

9.54

1.0

1.3

—

303.33

—

Explicit bacterial Sepsis

10.02

8.64

1.1

1.7

—

Atrial fibrillation and flutter with reimbursement

6.87

8.06

1.1

1.0

—

Acute nephritic syndrome

20.23

7.14

1.1

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

5.76

6.75

1.0

—

Other specified/unspecified systemic involvement of connective tissue

16.73

6.74

1.0

—

Lymphoid leukaemia

6.69

6.31

1.1

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

14.75

6.00

1.0

2.4

—

Diverticular disease of intestine

2.52

5.70

1.1

1.3

—

303.33

—

General examination and investigation of persons without complaint and reported diagnosis

2.56

5.52

1.2

1.1

—

610.00

—

Substance abuse, excluding more controls

113

2.48

5.27

1.1

1.3

—

470.00

—

Seropositive rheumatoid arthritis

4.33

5.27

1.1

—

Later onset COPD, excluding more controls

5.36

5.18

1.0

—

Other arthritis (FG)

3.34

5.15

1.0

1.1

—

Other nutritional deficiencies

143

2.32

5.01

1.1

1.3

—

303.33

—

Disorders of lipoprotein metabolism and other lipidaemias

104

2.30

4.95

1.0

1.3

—

303.33

—

Secondary hypertension

8.93

4.75

1.0

—

Chronic nephritic syndrome

14.06

4.58

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.36

4.57

1.3

1.1

—

610.00

—

Streptococcal septicaemia

8.20

4.56

1.1

1.0

—

Atrial fibrillation and flutter

3.97

4.49

1.1

1.0

—

COPD (mode)

3.71

4.39

1.0

—

Oxicams

3.50

4.18

1.3

1.0

—

Cardiomyopathy

4.08

4.15

1.1

—

Injuries to the head

190

1.85

4.13

1.1

1.2

—

438.57

—

Substance abuse

142

2.15

3.99

1.1

—

562.00

—

Budesonide

6.44

3.98

1.0

—

Infections of the skin and subcutaneous tissue

157

2.09

3.87

1.1

—

562.00

—

Psychiatric diseases

143

1.86

3.86

1.1

1.3

—

438.57

—

Obesity

137

2.17

3.85

1.1

1.3

—

303.33

—

Persons encountering health services for specific procedures, not carried out

12.02

3.76

1.0

—

Disorders of tooth development and eruption

5.86

3.73

1.4

1.5

—

Mental and behavioural disorders due to psychoactive substance use

145

2.08

3.69

1.1

—

562.00

—

Obesity and other hyperalimentation

140

2.12

3.65

1.1

1.3

—

303.33

—

Symptoms and signs involving the digestive system and abdomen

136

1.84

3.59

1.1

1.3

—

514.00

—

Symptoms and signs involving the skin and subcutaneous tissue

162

2.03

3.59

1.1

1.2

—

314.00

—

Any mental disorder

147

1.81

3.57

1.1

1.3

—

438.57

—

Type 1 diabetes

2.65

3.54

1.0

1.2

—

Myalgia

3.17

3.49

1.2

1.0

—

Benign neoplasm of other and ill-defined parts of digestive system

3.55

3.48

1.0

—

Other CVD (FINNGEN)

7.88

3.41

1.0

—

Other diseases of intestines

167

1.78

3.40

1.1

1.2

—

438.57

—

Episodal and paroxysmal disorders

165

1.74

3.39

1.1

1.2

—

470.00

—

Abdominal and pelvic pain

136

1.81

3.36

1.1

1.3

—

514.00

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

7.03

3.36

1.1

1.0

—

Stomatitis and related lesions

7.01

3.36

1.0

1.8

—

Ischaemic heart disease, wide definition

2.06

3.34

1.0

1.1

—

362.00

—

Chronic periapical parodontitis

3.25

3.34

1.1

1.2

—

Elevated blood glucose level

5.34

3.19

1.0

1.1

—

Neurological diseases, wide definition

3.20

3.12

1.1

1.3

—

Ischemic heart diseases

100

2.00

3.12

1.0

1.1

—

362.00

—

Anxiety disorders, excluding more controls

124

1.87

2.88

1.1

1.3

—

438.57

—

Viral hepatitis, IBD co-morbidity

8.35

2.75

1.0

—

Hypoplasia of dental enamel , including avohilmo

3.73

2.64

1.6

1.3

—

Hypoplasia of dental enamel, including avohilmo

4.75

2.61

1.6

1.5

—

Respiratory insufficiency

7.13

2.54

1.0

1.1

—

Benign neoplasm: Descending colon

5.47

2.54

1.0

—

Molar incisor enamel hypoplasia

3.55

2.52

1.6

1.3

—

Neurotic, stress-related and somatoform disorders

162

1.71

2.49

1.1

1.2

—

510.00

—

Emphysema

6.26

2.37

1.2

1.0

—

Molar incisor enamel hypoplasia, with caries

4.18

2.36

1.6

1.5

—

Medical observation and evaluation for suspected diseases and conditions

1.91

2.35

1.2

1.1

—

610.00

—

Anxiety disorders

165

1.68

2.32

1.1

1.2

—

510.00

—

5-aminosalicylic acid

2.86

2.30

1.1

—

Gingival hyperplasia

5.57

2.21

1.0

—

Other disorders of gingiva or/and edentulous alveolar ridge

5.57

2.21

1.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

5.56

2.21

1.0

—

Parodontitis, under 40 years and operation codes

3.20

2.09

1.3

1.1

—

Parodontitis, operation under 40 years and operation codes

3.20

2.09

1.3

1.1

—

Parodontitis, under 40 years

3.20

2.09

1.3

1.1

—

Parodontitis, under 40 years, or operation codes

3.20

2.09

1.3

1.1

—

Exposure to other specified factors

185

1.67

2.08

1.1

1.2

—

438.57

—

Type 1 diabetes, wide definition

2.26

2.06

1.0

1.3

—

Paroxysmal tachycardia

2.73

2.06

1.0

1.3

—

Benign neoplasm: Stomach

3.50

2.05

1.0

—

Benign neoplasm: Rectum

2.73

1.93

1.1

1.0

—

Low back pain

131

1.70

1.91

1.1

1.3

—

114.00

—

Polymyalgia rheumatica

3.53

1.83

1.0

—

Type 1 diabetes, wide definition, subgroup 1

2.20

1.83

1.0

1.3

—

Other diseases of lip and oral mucosa

2.76

1.79

1.0

—

Adjustment and management of implanted device

2.76

1.79

1.3

1.1

—

Fenamates

2.84

1.75

1.1

1.0

—

Enlarged lymph nodes

3.34

1.74

1.2

1.1

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

3.85

1.71

1.2

1.0

—

Persons encountering health services for examination and investigation

1.74

1.70

1.2

1.1

—

610.00

—

Benign neoplasm: Adrenal gland

3.58

1.61

1.0

—

Benign neoplasm of other and unspecified endocrine glands

2.69

1.58

1.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

2.63

1.53

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.34

1.52

1.4

1.1

—

Other blood glucose lowering drugs, excl. Insulins

2.59

1.51

1.0

—

Fall on same level

187

1.43

1.50

1.1

1.2

—

438.57

—

Sulfasalazine

2.37

1.45

1.0

—

Childhood asthma (age<16)

2.53

1.43

1.0

—

Childhood asthma (age<16), excluding more controls

2.52

1.43

1.0

—

Other disorders of penis

2.42

1.39

2.0

1.1

—

Misadventures to patients during surgical and medical care

2.61

1.36

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.94

1.36

1.0

1.1

—

Lung cancer and mesothelioma

2.57

1.32

1.0

—

Other antidepressants

140

1.45

1.32

1.0

1.3

—

438.57

—

Benign neoplasm: Caecum

2.78

1.28

1.0

—

Selective serotonin reuptake inhibitors

147

1.43

1.27

1.0

1.3

—

438.57

—

Mood disorders, excluding more controls

137

1.47

1.21

1.0

1.3

—

438.57

—

Non-follicular lymphoma, hilmo, excluding all cancers

2.63

1.21

1.0

—

Melanocytic naevi of trunk

2.63

1.21

1.0

—

Falls/tendency to fall

165

1.37

1.11

1.1

1.2

—

470.00

—

Trigger finger

2.17

0.98

1.0

1.1

—

Sleep disorders (combined)

173

1.36

0.96

1.1

1.2

—

470.00

—

Spondyloarthritis

2.07

0.89

1.0

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

1.94

0.84

1.0

—

Adhesive capsulitis of shoulder

1.94

0.84

1.2

1.1

—

Other disorders of ear

164

1.34

0.82

1.0

1.3

—

303.33

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.81

0.0

1.1

—

Prolonged pregnancy

0.00

0.79

0.0

1.0

—

Disorders of speech understanding and production

0.00

0.79

0.0

1.4

—

Motor disorders

0.00

0.79

0.0

1.4

—

Eating disorder

0.00

0.79

0.0

1.1

—

Erosion of teeth, including avohilmo

1.81

0.78

1.2

1.3

—

Pure hypercholesterolaemia

1.44

0.78

1.0

1.1

—

362.00

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.13

0.75

1.0

1.3

—

Maternal care for known or suspected abnormality of pelvic organs

1.79

0.72

1.0

1.1

—

Benzodiazepine use

180

1.30

0.72

1.0

1.2

—

303.33

—

Depression or dysthymia

102

1.37

0.71

1.0

1.3

—

438.57

—

Impingement syndrome of shoulder

1.75

0.71

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

190

1.26

0.69

1.0

1.2

—

303.33

—

Allergic asthma (mode), excluding more controls

1.68

0.68

1.4

1.0

—

Valvular operations

1.85

0.68

1.2

1.3

—

Sleep apnoea

155

1.31

0.68

1.1

1.2

—

314.00

—

Dental caries 2 and operation codes, only avohilmo

135

0.69

0.68

1.1

—

610.00

—

Type 1 diabetes, strict (exclude DM2)

1.62

0.66

1.0

1.3

—

Type 1 diabetes, definitions combined

1.62

0.66

1.0

1.3

—

Acute appendicitis

161

1.35

0.65

1.0

1.3

—

438.57

—

Mood [affective] disorders

182

1.26

0.62

1.0

1.2

—

438.57

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.60

0.0

1.1

—

Rheumatism, unspecified

0.00

0.60

0.0

1.1

—

Mood disorders

183

1.26

0.59

1.0

1.2

—

438.57

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.0

—

Specific developmental disorder of motor function

0.00

0.59

0.0

1.5

—

Depression

169

1.26

0.56

1.0

1.2

—

438.57

—

Diseases of the ear and mastoid process

174

1.22

0.55

1.1

1.2

—

438.57

—

Type 1 diabetes, strict definition

1.54

0.53

1.0

1.3

—

Dental caries 2 and operation codes

156

1.27

0.50

1.1

1.2

—

562.00

—

Allergic asthma (mode)

1.49

0.47

1.4

1.0

—

Pregnancy, childbirth and the puerperium

1.44

0.43

1.1

1.0

—

Dental caries 2

158

1.24

0.43

1.1

1.2

—

562.00

—

Appendicitis, broad definition

169

1.24

0.41

1.0

1.3

—

438.57

—

Conotruncal defects

0.00

0.41

0.0

1.7

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.41

0.0

1.5

—

Abnormalities of forces of labour

0.00

0.41

0.0

1.0

—

Constipation

171

1.21

0.41

1.0

1.2

—

314.00

—

Disorders of puberty, all

0.00

0.41

0.0

1.3

—

Malignant neoplasm of corpus uteri

0.00

0.41

0.0

1.1

—

Emotional disorders starting during childhood or adolescence

1.50

0.41

1.0

1.4

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.0

—

Hyperkinetic disorders (excl. ADHD)

0.00

0.40

0.0

1.5

—

Sleep apnoea, including avohilmo

161

1.21

0.40

1.1

1.2

—

314.00

—

Diseases of appendix

169

1.24

0.40

1.0

1.3

—

438.57

—

Exclusion endpoint for clefts

0.00

0.40

0.0

1.5

—

Other eating disorders

0.00

0.40

0.0

1.1

—

Metatarsalgia

0.00

0.40

0.0

1.1

—

KRA_PSY_EATING, excluding more controls

0.00

0.40

0.0

1.0

—

Motor disorders, excluding more controls

0.00

0.39

0.0

1.4

—

Haemangioma, any site

0.00

0.39

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

0.39

0.0

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.41

0.38

1.0

1.3

—

Type 1 diabetes, strict definition, subgroup 1

1.39

0.38

1.0

1.3

—

Injuries to the ankle and foot

171

1.23

0.37

1.0

1.2

—

470.00

—

Gastro-oesophageal reflux disease

135

1.25

0.35

1.0

1.3

—

314.00

—

Type1 diabetes, definitions combined, early onset

1.42

0.35

1.0

1.3

—

Abrasion of teeth

1.38

0.35

1.0

1.1

—

Dental operations, only avohilmo

106

1.21

0.33

1.0

1.3

—

114.00

—

Dental caries 2, only avohilmo

166

0.81

0.33

1.1

1.2

—

562.00

—

Persons encountering health services in circumstances related to reproduction

126

0.81

0.29

1.2

1.3

—

362.00

—

Coxibs

1.25

0.28

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.65

0.26

1.0

—

Other diseases of upper respiratory tract

181

1.12

0.24

1.2

1.1

—

510.00

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

144

0.85

0.24

1.2

—

562.00

—

Triptan medication for migraine, single purchase ok

144

0.85

0.24

1.2

—

562.00

—

Dental caries 1, only avohilmo

125

1.15

0.23

1.0

1.3

—

114.00

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.21

0.0

1.3

—

Birth asphyxia

0.00

0.21

0.0

1.3

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

1.9

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.21

0.0

1.9

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.21

0.0

1.1

—

Mandibular prognathia

0.00

0.21

0.0

1.9

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.21

0.0

1.1

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Other obstructed labour

0.00

0.21

0.0

1.0

—

Multiple delivery

0.00

0.21

0.0

1.1

—

Female infertility, associated with anovulation

0.00

0.21

0.0

1.0

—

Twin gestation

0.00

0.21

0.0

1.0

—

Other disorders originating in the perinatal period

0.00

0.21

0.0

1.2

—

Disorders of puberty

0.00

0.21

0.0

1.2

—

Congenital deformities of hip

0.00

0.21

0.0

1.3

—

Congenital malformations of the nervous system

0.00

0.21

0.0

1.7

—

Use of galantamine

0.00

0.21

0.0

1.1

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

1.1

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

1.1

—

Multiple gestation

0.00

0.21

0.0

1.0

—

Family history of malignant neoplasm

0.00

0.21

0.0

1.0

—

Early lumbar disc prolapse operation

0.00

0.21

0.0

1.0

—

Fall involving playground equipment

0.00

0.21

0.0

1.8

—

Slow fetal growth and fetal malnutrition

0.00

0.21

0.0

1.6

—

Polycystic ovarian syndrome, broad definition

0.00

0.21

0.0

1.1

—

Other infections specific to the perinatal period

0.00

0.20

0.0

1.8

—

Desensitization to allergens

0.00

0.20

0.0

1.2

—

Fibromyalgia

0.00

0.20

0.0

1.1

—

Early lumbar disc prolapse, operated

0.00

0.20

0.0

1.0

—

Injuries to the wrist and hand

208

1.11

0.20

1.1

1.2

—

438.57

—

Other medical care

1.18

0.12

1.1

—

Fracture of lower leg, including ankle

142

1.12

0.12

1.0

1.3

—

314.00

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.08

0.09

1.0

—

Excessive attrition of teeth

0.79

0.08

1.2

1.1

—

Recurrent or chronic depression

1.07

0.07

1.0

1.5

—

562.00

—

Cholecystectomy

131

1.08

0.06

1.0

1.2

—

314.00

—

Hernia

169

1.04

0.03

1.2

—

438.57

—

Chronic diseases of tonsils and adenoids

152

0.96

0.03

1.5

1.1

—

510.00

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Other congenital malformations of peripheral vascular system

0.00

0.0

1.0

—

Chronic respiratory disease originating in the perinatal period

0.00

0.0

2.4

—

Cyst of Bartholin Gland

0.00

0.0

1.0

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Congenital malformations of gallbladder, bile ducts and liver

0.00

0.0

1.1

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.1

—

Other maltreatment syndromes

0.00

0.0

1.0

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.0

1.0

—

Other and unspecified acne

0.00

0.0

1.0

—

Inflammatory disorders of breast

0.00

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Male infertility

0.00

0.0

1.0

—

Other benign neoplasms of uterus

0.00

0.0

1.1

—

Bicipital tendinitis

0.00

0.0

1.0

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Other congenital malformations of limb(s)

0.00

0.0

1.0

—

Polycystic ovarian syndrome

0.00

0.0

1.0

—

Complications of other internal prosthetic devices, implants and grafts

0.00

0.0

1.2

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Malignant neoplasm of ovary

0.00

0.0

1.2

—

Serous carcinoma of ovary

0.00

0.0

1.2

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Ovarian dysfunction

0.00

0.0

1.1

—

Hypoparathyroidism

0.00

0.0

1.0

—

Allergic contact dermatitis due to drugs in contact with skin

0.00

0.0

1.0

—

Other congenital malformations of skull and face bones

0.00

0.0

1.0

—

Moderate visual impairment, binocular

0.00

0.0

1.2

—

Other congenital musculoskeletal deformities

0.00

0.0

1.0

—

Other puerperal infections

0.00

0.0

1.0

—

Other disturbances of cerebral status of newborn

0.00

0.0

1.0

—

Benign neoplasm: Skin of lower limb, including hip

0.00

0.0

1.0

—

Benign neoplasm of urinary organs

0.00

0.0

1.0

—

Feeding problems of newborn

0.00

0.0

1.2

—

Bilateral sagittal split ramus osteotomy operation

0.00

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.0

—

Carcinoma in situ of skin of trunk

0.00

0.0

1.0

—

Burn and corrosion of head and neck

0.00

0.0

1.0

—

Other congenital malformations of intestine

0.00

0.0

1.1

—

Postpartum haemorrhage due to anatomy

0.00

0.0

1.0

—

Other obstetric trauma

0.00

0.0

1.0

—

Acetic acid derivatives and related substances

0.95

0.00

1.0

—

Abnormal findings on antenatal screening of mother

0.00

0.0

1.1

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.0

1.0

—

Superficial injury of neck

0.00

0.0

1.0

—

Other disorders of male genital organs

0.00

0.0

1.0

—

Sacrococcygeal disorders, not elsewhere classified

0.00

0.0

1.0

—

Family history of other conditions

0.00

0.0

1.0

—

Benign neoplasm: Skin, unspecified

0.00

0.0

1.0

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Delivery, wide proxy

0.91

0.00

1.0

1.1

—

Congenital malformations of spine and bony thorax

0.00

0.0

1.0

—

Disorder of the sleep-wake schedule

0.00

0.0

1.0

—

Torsion of testis

0.00

0.0

1.3

—

Other specified disorders of muscle

0.00

0.0

1.0

—

Benign neoplasm: Skin of lower limb, including hip

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Other congenital malformations of heart

0.00

0.0

1.0

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

1.0

—

Other benign neoplasms of uterus

0.00

0.0

1.0

—

Social disorders starting during childhood or adolescence

0.00

0.0

1.2

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.0

—

Palatinal maxillary operation

0.00

0.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

0.0

1.0

—

Palatinal maxillary canine

0.00

0.0

1.1

—

Maxillary prognathism

0.00

0.0

1.0

—

Mesial bite

0.00

0.0

1.3

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.0

1.0

—

Complex cardiac defects

0.00

0.0

1.0

—

Precocious central puberty

0.00

0.0

1.0

—

Right ventricular outflow tract obstruction

0.00

0.0

1.2

—

Deep bite that required surgery

0.00

0.0

1.0

—

Asymmetry of jaw

0.00

0.0

1.0

—

Mandibular retrognathia AND surgery (BSSRO)

0.00

0.0

1.0

—

Excessive vomiting in pregnancy

0.00

0.0

1.0

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.00

0.0

1.2

—

Hodgkin lymphoma

0.00

0.0

1.0

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

0.0

2.3

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Suppurative otitis media, unspecified

0.00

0.0

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

0.0

1.0

—

Unspecified visual impairment (binocular)

0.00

0.0

1.1

—

Other and unspecified hydrocephalus

0.00

0.0

1.0

—

Intentional self-harm by sharp object

0.00

0.0

1.0

—

Generalized epilepsy, strict definition

0.00

0.0

1.2

—

Congenital malformations of pulmonary and tricuspid valves

0.00

0.0

1.1

—

Benign neoplasm: Skin of scalp and neck

0.00

0.0

1.0

—

Constitutional tall stature

0.00

0.0

1.0

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.0

1.0

—

Other perinatal haematological disorders

0.00

0.0

1.0

—

Radial styloid tenosynovitis [de Quervain]

0.00

0.0

1.1

—

Congenital malformations of cardiac chambers and connections

0.00

0.0

1.1

—

Other demyelinating diseases of the central nervous system

0.00

0.0

1.0

—

Precocious puberty

0.00

0.0

1.0

—

Drug-induced adrenocortical insufficiency

0.00

0.0

1.0

—

Delayed puberty

0.00

0.0

1.3

—

Congenital malformation of biliary tract

0.00

0.0

1.1

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

0.0

1.0

—

Other abnormal immunological findings in serum

0.00

0.0

1.0

—

Juvenile rheumatoid arthirtis

0.00

0.0

1.0

—

Juvenile osteochondrosis

0.00

0.0

1.1

—

Patellar tendinitis

0.00

0.0

1.0

—

Viral meningitis

0.00

0.0

1.0

—

Other congenital malformations of ear

0.00

0.0

1.0

—

Unspecified abortion

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS